The patient has received chemotherapy, radiotherapy (except for palliative reasons), immunotherapy, or targeted therapy for gastric cancer within  weeks of study treatment
Participants receiving any systemic chemotherapy, radiotherapy (except for palliative reasons), within  weeks from the last dose prior to study treatment (or a longer period depending on the defined characteristics of the agents used); the patient can receive a stable dose of bisphosphonates for bone metastases, before and during the study as long as these were started at least  weeks prior to treatment with olaparib and temozolomide
Patients receiving any systemic chemotherapy or radiotherapy (except for palliative reasons) within  weeks prior to study treatment
Patients receiving any systemic chemotherapy or radiotherapy (except for palliative reasons) within  weeks prior to study treatment initiation
Patients receiving any systemic chemotherapy, radiotherapy (except for palliative reasons), within  weeks from the last dose prior to study treatment; the patient can receive a stable dose of bisphosphonates for bone metastases, before and during the study as long as these were started at least  weeks prior to treatment with study drug
Patients receiving any systemic chemotherapy or radiotherapy (except for palliative reasons) within  weeks prior to study treatment
Patients receiving any systemic chemotherapy or radiotherapy (except for palliative reasons) within  weeks prior to study treatment.
Radiotherapy (except for palliative reasons) the previous two weeks before.
Patients receiving any systemic chemotherapy or radiotherapy (except for palliative reasons) within  weeks prior to study treatment
Patients receiving any systemic chemotherapy within  weeks prior to first dose of study treatment
Radiotherapy (except for palliative reasons), targeted therapy, or immunotherapy (except for uveal melanoma) the previous four weeks before study treatment.
Subjects receiving any systemic chemotherapy or radiotherapy (except for palliative reasons) within  weeks prior to study treatment;